SCHEMBL13648293

SCHEMBL13648293

C#CCC[C@@H](C(=C)O)[C@H](O)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 3/20 0.37
SLC6A2 P23975 4/20 0.36
SLC6A4 P31645 4/20 0.36
SLC6A3 Q01959 4/20 0.36
ALDH1A1 P00352 3/20 0.36
ADRA2C P18825 2/20 0.35
KDM4E B2RXH2 2/20 0.35
LMNA P02545 2/20 0.35
ADRA2A P08913 1/20 0.35
HIF1A Q16665 1/20 0.35
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
CHRM2 P08172 1/20 0.33
ADRA1A P35348 1/20 0.33
RGS12 O14924 1/20 0.33
GLA P06280 1/20 0.33
CYP2C9 P11712 1/20 0.33
PKM P14618 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL907522 0.83 LMNA (0.41) AOC3SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL907525 0.83 LMNA (0.41) AOC3SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL27692795 0.74 RIPK1 (0.50) AOC3KDM4ELMNATSHR
SCHEMBL2496078 0.74 RIPK1 (0.50) AOC3KDM4ELMNATSHR
SCHEMBL16119950 0.72 AOC3 (0.45) AOC3SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL21163942 0.72 AOC3 (0.45) AOC3SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL18893313 0.72 AOC3 (0.45) AOC3SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL18887989 0.72 AOC3 (0.49) AOC3SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL30804695 0.71 CYP1A2 (0.40) AOC3SLC6A2SLC6A4SLC6A3CYP2D6
SCHEMBL28900854 0.71 CYP1A2 (0.40) AOC3SLC6A2SLC6A4SLC6A3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009124167-A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK & CO., INC. (US) 2009-10-08 WO disclosed